Wells Fargo Maintains Equal-Weight on Bio-Rad Laboratories, Raises Price Target to $330

Wells Fargo analyst Evan Stampler maintains Bio-Rad Laboratories (NYSE:BIO) with a Equal-Weight and raises the price target from $310 to $330.